David Cohen

Bio: David Cohen is an academic researcher from Pierre-and-Marie-Curie University. The author has contributed to research in topics: Medicine & Autism. The author has an hindex of 83, co-authored 635 publications receiving 37722 citations. Previous affiliations of David Cohen include University of California, Berkeley & University of Michigan.

Coping, suicidalité et trouble de personnalité limite à l’adolescence

Abstract: Resume Le trouble de personnalite limite est le plus important facteur de risque independant des conduites suicidaires a l’adolescence. Or, depuis peu, un nouveau regard est porte sur l’evaluation du risque suicidaire, mettant l’accent sur les facteurs de protection dont les strategies de coping . Le propos de cet article est double. Premierement, a partir de l’etude des donnees recentes de la litterature, il souligne l’interet d’etudier et de developper les strategies de coping chez les adolescents suicidants ayant un trouble de personnalite limite. Deuxiemement, sont decrits les resultats preliminaires d’une etude concernant le profil de coping d’adolescents suicidants ayant un trouble de personnalite limite. Sous reserve des analyses portant sur la totalite de l’echantillon, les adolescents suicidants different par leur profil de coping selon qu’ils presentent ou pas un trouble de personnalite limite. Au regard d’un modele theorique innovant integrant facteurs de risque et de protection applique aux resultats de l’etude actuelle, developper les strategies de coping productif (facteur de protection) chez ces adolescents pourrait diminuer l’intensite de certaines dimensions (telles que l’instabilite emotionnelle et l’impulsivite) du construit trouble de personnalite limite (facteur de vulnerabilite) et donc le risque suicidaire.

The Cost-Effectiveness of Transcatheter Aortic Valve Replacement for Nonsurgical Candidates Revisionist History or the Final Word?

Abstract: > Prediction is very difficult, especially if it’s about the future > > Neils Bohr Life expectancy in the United States has steadily increased in the past century, from just <60 years in 1930, to just <70 years in 1960, and to just <80 years in 2010. Progress, however, has its price. The numbers of elderly and very elderly members of the population in the United States and other developed nations are increasing rapidly along with their age-related health problems. At the same time, healthcare spending has risen dramatically. As new medical treatments have become more expensive to discover and produce, and the incremental benefits those treatments provide have become smaller, there is a growing perception that the return on continued increases in healthcare spending may be diminishing.1 Article see p 419 Into this milieu enters transcatheter aortic valve replacement (TAVR), a therapy that is currently revolutionizing the approach to managing aortic stenosis (AS)—a condition, mainly, of the elderly. Cohort B of the Placement of Aortic Transcatheter Valves (PARTNER) trial,2 along with a number of nonrandomized studies, has shown that TAVR can greatly improve health outcomes in the important minority of patients with severe AS who are felt to be at prohibitive risk for surgical intervention. In this setting, TAVR reduced all-cause mortality by absolute margins of 20% and 25% at 1 and 2 years, respectively, while substantially improving functional status and quality of life, compared with medical management.2–4 Although the clinical benefits of TAVR for the inoperable population are unquestionably large, so too are the financial costs, not only of the treatment itself but also for the ongoing medical care of patients who are, on average, octogenarians with complex medical problems. Consequently, payers in varied settings have needed to carefully examine the affordability and value of TAVR …

Abstracts from Hydrocephalus 2016.

Abstract: s from Hydrocephalus 2016 Cartagena, Colombia. 8–10 October 2016 © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. A1 Barriers to standardizing care for hydrocephalus in the Middle East A. Adam, J. Robison, J. Lu, R. Jose, N. Badran, T. Vivas‐Buitrago, D. Rigamonti Johns Hopkins University, Baltimore, MD, USA; Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia Correspondence: A. Adam Fluids and Barriers of the CNS 2017, 14(Suppl 1):A

Troubles développementaux de la coordination (TDC) : perspective clinique et synthèse de l’état des connaissances

Abstract: Resume Les troubles praxiques constituent un motif frequent de consultation en psychiatrie de l’enfant et de l’adolescent. Nous proposons une synthese de l’etat actuel des connaissances utile au clinicien confronte a ces troubles. Les dyspraxies de developpement correspondent au regard du DSM-5 aux troubles developpementaux de la coordination (TDC). Nous aborderons les differents aspects de la clinique de ces troubles, en y integrant des points de vue etiologique et physiopathologique. L’accent sera mis sur la place des TDC dans le champ de la psychiatrie et notamment sur leur retentissement precoce sur le developpement psychoaffectif de l’enfant, les problematiques d’apprentissage scolaire et la qualite de son inscription sociale. La frequence des pathologies co-occurrentes aux TDC et leur inclusion dans des tableaux cliniques complexes plaideront pour la necessite de les apprehender en tenant compte du fonctionnement global de l’enfant ou de l’adolescent. C’est en ce sens que nous presenterons les principes de leur prise en charge.

Using Multivariate Statistics

Abstract: Thank you for downloading using multivariate statistics. As you may know, people have look hundreds times for their favorite novels like this using multivariate statistics, but end up in infectious downloads. Rather than reading a good book with a cup of tea in the afternoon, instead they juggled with some harmful bugs inside their laptop. using multivariate statistics is available in our digital library an online access to it is set as public so you can download it instantly. Our books collection saves in multiple locations, allowing you to get the most less latency time to download any of our books like this one. Merely said, the using multivariate statistics is universally compatible with any devices to read.

How people learn: Brain, mind, experience, and school.

Abstract: New developments in the science of learning science of learning overview mind and brain how experts differ from novices how children learn learning and transfer the learning environment curriculum, instruction and commnity effective teaching - examples in history, mathematics and science teacher learning technology to support learning conclusions from new developments in the science of learning.

ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

Abstract: ACE : angiotensin-converting enzyme ACS : acute coronary syndrome ADP : adenosine diphosphate AF : atrial fibrillation AMI : acute myocardial infarction AV : atrioventricular AIDA-4 : Abciximab Intracoronary vs. intravenously Drug Application APACHE II : Acute Physiology Aand Chronic

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

Abstract: WRITING GROUP MEMBERS Emelia J. Benjamin, MD, SCM, FAHA Michael J. Blaha, MD, MPH Stephanie E. Chiuve, ScD Mary Cushman, MD, MSc, FAHA Sandeep R. Das, MD, MPH, FAHA Rajat Deo, MD, MTR Sarah D. de Ferranti, MD, MPH James Floyd, MD, MS Myriam Fornage, PhD, FAHA Cathleen Gillespie, MS Carmen R. Isasi, MD, PhD, FAHA Monik C. Jiménez, ScD, SM Lori Chaffin Jordan, MD, PhD Suzanne E. Judd, PhD Daniel Lackland, DrPH, FAHA Judith H. Lichtman, PhD, MPH, FAHA Lynda Lisabeth, PhD, MPH, FAHA Simin Liu, MD, ScD, FAHA Chris T. Longenecker, MD Rachel H. Mackey, PhD, MPH, FAHA Kunihiro Matsushita, MD, PhD, FAHA Dariush Mozaffarian, MD, DrPH, FAHA Michael E. Mussolino, PhD, FAHA Khurram Nasir, MD, MPH, FAHA Robert W. Neumar, MD, PhD, FAHA Latha Palaniappan, MD, MS, FAHA Dilip K. Pandey, MBBS, MS, PhD, FAHA Ravi R. Thiagarajan, MD, MPH Mathew J. Reeves, PhD Matthew Ritchey, PT, DPT, OCS, MPH Carlos J. Rodriguez, MD, MPH, FAHA Gregory A. Roth, MD, MPH Wayne D. Rosamond, PhD, FAHA Comilla Sasson, MD, PhD, FAHA Amytis Towfighi, MD Connie W. Tsao, MD, MPH Melanie B. Turner, MPH Salim S. Virani, MD, PhD, FAHA Jenifer H. Voeks, PhD Joshua Z. Willey, MD, MS John T. Wilkins, MD Jason HY. Wu, MSc, PhD, FAHA Heather M. Alger, PhD Sally S. Wong, PhD, RD, CDN, FAHA Paul Muntner, PhD, MHSc On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics—2017 Update

Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

Abstract: Author(s): Writing Group Members; Mozaffarian, Dariush; Benjamin, Emelia J; Go, Alan S; Arnett, Donna K; Blaha, Michael J; Cushman, Mary; Das, Sandeep R; de Ferranti, Sarah; Despres, Jean-Pierre; Fullerton, Heather J; Howard, Virginia J; Huffman, Mark D; Isasi, Carmen R; Jimenez, Monik C; Judd, Suzanne E; Kissela, Brett M; Lichtman, Judith H; Lisabeth, Lynda D; Liu, Simin; Mackey, Rachel H; Magid, David J; McGuire, Darren K; Mohler, Emile R; Moy, Claudia S; Muntner, Paul; Mussolino, Michael E; Nasir, Khurram; Neumar, Robert W; Nichol, Graham; Palaniappan, Latha; Pandey, Dilip K; Reeves, Mathew J; Rodriguez, Carlos J; Rosamond, Wayne; Sorlie, Paul D; Stein, Joel; Towfighi, Amytis; Turan, Tanya N; Virani, Salim S; Woo, Daniel; Yeh, Robert W; Turner, Melanie B; American Heart Association Statistics Committee; Stroke Statistics Subcommittee